|
Delayed
Sao Paulo
08:56:40 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 60.49 BRL | -5.16% |
|
-8.35% | -14.69% |
| 02/10 | Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating | MT |
| 02/10 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 7.34TCr 38TCr 6.52TCr 6.09TCr 5.55TCr 10TCr 7,05700Cr 11TCr 74TCr 29TCr 3,60800Cr 28TCr 27TCr 11,57900Cr | P/E 2026 * |
16.8x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 6.6TCr 35TCr 5.86TCr 5.47TCr 4.99TCr 9.41TCr 6,34400Cr 9.49TCr 66TCr 26TCr 3,24300Cr 25TCr 24TCr 10,40800Cr | EV / Sales 2026 * |
3.88x | EV / Sales 2027 * | 3.41x |
| Free-Float |
71.06% | Yield 2026 * |
0.53% | Yield 2027 * | 0.6% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -5.16% | ||
| 1 week | -8.35% | ||
| Current month | -7.58% | ||
| 1 month | -14.09% | ||
| 3 months | +8.66% | ||
| 6 months | -7.42% | ||
| Current year | -14.69% |
| 1 week | 60.3 |  | 65.45 |
| 1 month | 60.3 | | 70.6 |
| Current year | 50 | | 73.16 |
| 1 year | 49.65 | | 73.33 |
| 3 years | 44.82 | | 111.72 |
| 5 years | 44.82 | | 111.72 |
| 10 years | 18.16 | | 111.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.16% | -8.35% | - | - | 7.34TCr | |
| +0.61% | -2.68% | +36.44% | +112.93% | 1,01900Cr | |
| -0.77% | -6.69% | +34.86% | +61.48% | 62TCr | |
| +0.12% | -1.33% | +14.14% | +78.20% | 46TCr | |
| -3.12% | -6.13% | +57.17% | +34.72% | 36TCr | |
| +0.93% | -1.83% | +20.98% | +41.43% | 33TCr | |
| +0.12% | -4.05% | +10.09% | +33.53% | 27TCr | |
| -0.89% | -5.83% | -7.56% | +7.91% | 24TCr | |
| -0.47% | -4.40% | +35.91% | +50.80% | 22TCr | |
| -0.65% | -5.50% | +26.64% | +92.56% | 18TCr | |
| Average | -1.01% | -3.54% | +25.41% | +57.06% | 41.08TCr | |
| Weighted average by Cap. | -0.42% | -3.54% | +28.67% | +68.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.7TCr 8.91TCr 1.51TCr 1.41TCr 1.29TCr 2.43TCr 1,63600Cr 2.45TCr 17TCr 6.62TCr 84TCr 6.39TCr 6.25TCr 2,68300Cr | 1.85TCr 9.69TCr 1.64TCr 1.54TCr 1.4TCr 2.64TCr 1,78000Cr 2.66TCr 19TCr 7.2TCr 91TCr 6.95TCr 6.8TCr 2,92000Cr |
| Net income | 495.16Cr 2.59TCr 439.95Cr 410.62Cr 374.27Cr 705.87Cr 48TCr 712.44Cr 4.97TCr 1.93TCr 24TCr 1.86TCr 1.82TCr 78TCr | 548.58Cr 2.87TCr 487.41Cr 454.92Cr 414.64Cr 782.02Cr 53TCr 789.3Cr 5.51TCr 2.13TCr 27TCr 2.06TCr 2.01TCr 87TCr |
| Net Debt | -742.2Cr -3.89TCr -659.45Cr -615.49Cr -561Cr -1.06TCr -71TCr -1.07TCr -7.45TCr -2.89TCr -36TCr -2.79TCr -2.73TCr -1,17100Cr | -1.03TCr -5.4TCr -916.55Cr -855.45Cr -779.71Cr -1.47TCr -99TCr -1.48TCr -10TCr -4.01TCr -51TCr -3.87TCr -3.79TCr -1,62700Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | R$60.49 | -5.16% | 3,250 |
| 02/26/02 | R$63.78 | -1.39% | 6,817 |
| 01/26/01 | R$64.68 | -1.18% | 58 |
| 30/26/30 | R$65.45 | +0.43% | 127 |
| 29/26/29 | R$65.17 | -1.26% | 348 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
- REGN34 Stock
Select your edition
All financial news and data tailored to specific country editions
